A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders
Recruiting
Observational Study
Insomnia
Psychiatric Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 121 (estimated)
- Sponsor
- Shanghai Mental Health Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the effectiveness and safety of lemborexant (a new dual orexin receptor antagonist) in the treatment of patients with mental disorders complicated with insomnia. The subjects are patients aged 18 years and above, who meet the DSM-5 diagnostic criteria for mental disorders and have an Insomnia Severity Index (ISI) score ≥11. They will receive lemborexant treatment for 8 …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged 18 years and above, regardless of gender;
2. Meet the DSM-5 diagnostic criteria for mental disorders (any type);
3. Insomnia Severity Index (ISI) score ≥11;
4. Have at least 7 hours of sleep time available;
5. Able to complete the 2-month scale assessment and follow-up p…
Contacts